Evidence mapPaperPMID 41454203Full record

ReviewAging clinical and experimental research2025

"This also matters to me": what does adherence to dementia risk reduction interventions mean to members of the public?

Ana Maria Diaz-Ponce, Sarah Campill, Mariagnese Barbera, Cindy Birck, Natalia Soldevila-Domenech, Laura Forcano Gamazo, Amaia Ayala-Garcia, Francesca Mangialasche, Jeroen Bruinsma, Marissa Zwan and 3 more

Abstract readReview
In one paragraph

Review in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ana Maria Diaz-PonceAlzheimer Europe, Senningerberg, Luxembourg. ana.diaz@alzheimer-europe.org.ORCID http://orcid.org/0000-0002-5533-0344
Sarah CampillAlzheimer Europe, Senningerberg, Luxembourg.ORCID http://orcid.org/0000-0002-0269-8751
Mariagnese BarberaDepartment of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0002-8983-1294
Cindy BirckAlzheimer Europe, Senningerberg, Luxembourg.ORCID http://orcid.org/0000-0002-0763-7544
Natalia Soldevila-DomenechClinical and Risk Factors for Neurodegenerative Diseases Research, Neuroscience Research Program, Hospital del Mar Research Institute, Barcelona, Spain.ORCID http://orcid.org/0000-0001-6024-8508
Laura Forcano GamazoIntegrative Pharmacology and Systems Neuroscience Group, Neuroscience Research Program, Hospital del Mar Research Institute, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8478-1451
Amaia Ayala-GarciaIntegrative Pharmacology and Systems Neuroscience Group, Neuroscience Research Program, Hospital del Mar Research Institute, Barcelona, Spain.ORCID http://orcid.org/0000-0002-0415-8177
Francesca MangialascheDivision of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, 171 76, Sweden.ORCID http://orcid.org/0000-0002-2686-3926
Jeroen BruinsmaDepartment of Health Promotion, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0002-7964-0267
Marissa ZwanAlzheimer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Neurology, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0879-2164
Tobias HartmannDeutsches Institut für Demenzprävention (DIDP), Neurodegeneration and Neurobiology and Experimental Neurology, Saarland University, 66424, Homburg/Saar, Germany.ORCID http://orcid.org/0000-0001-7481-6430
Rafael De La Torre-FornellAlzheimer Europe, Senningerberg, Luxembourg.ORCID http://orcid.org/0000-0002-6765-1866
Alina SolomonDepartment of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0002-7166-9903

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing evidence highlights the potential of multidomain lifestyle-based interventions to reduce the risk of cognitive decline among older adults at higher risk of cognitive impairment. Within these complex and often demanding interventions, adherence has emerged as a key factor influencing both outcomes and impact. Numerous studies have explored adherence from the perspective of researchers which is often defined as the extent to which a person's behaviour corresponds with agreed recommendations from a healthcare provider. However, less is known about how members of the public understand and experience it. This article presents insights gathered from Advisory Boards established within three European-funded projects, as part of Public Involvement activities led by Alzheimer Europe in collaboration with researchers in the projects. The discussions involved 23 members of the public (lay people with and without dementia) from nine European countries and focused on adherence in the context of research-based multidomain lifestyle interventions to reduce dementia risk. Feedback from Advisory Boards members were grouped in three overarching themes: (1) "Baking your own cake" which highlights the relevance and understandings of adherence from members of the public; (2) "Striking a balance" which refers to the complexity and influencing factors linked to adherence; and (3) "A two-way process" which emphasises the involvement of members of the public and the importance of clear communication and appropriate support throughout the intervention process. Promoting adherence requires recognising participants as active partners in research which may not only improve adherence itself but also enhance the relevance, effectiveness and long-term impact of dementia prevention efforts.

Indexed as

DementiaPatient ComplianceRisk Reduction BehaviorAgedCognitive DysfunctionEuropeFemaleHumansLife StyleMaleAdherenceDementiaIntensityLifestyle interventionMultimodal intervention

Identifiers

PMID41454203
PMCPMC12774978

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.